WO2003055528A3 - Composes amphiphiles a usage pharmaceutique ou cosmetique - Google Patents

Composes amphiphiles a usage pharmaceutique ou cosmetique Download PDF

Info

Publication number
WO2003055528A3
WO2003055528A3 PCT/FR2002/004561 FR0204561W WO03055528A3 WO 2003055528 A3 WO2003055528 A3 WO 2003055528A3 FR 0204561 W FR0204561 W FR 0204561W WO 03055528 A3 WO03055528 A3 WO 03055528A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical
cosmetic use
amphiphilic compounds
molecules
cosmetic
Prior art date
Application number
PCT/FR2002/004561
Other languages
English (en)
Other versions
WO2003055528A2 (fr
Inventor
Nicolas Calvet
Original Assignee
Physica S A R L
Nicolas Calvet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Physica S A R L, Nicolas Calvet filed Critical Physica S A R L
Priority to US10/499,542 priority Critical patent/US20050069513A1/en
Priority to AU2002364684A priority patent/AU2002364684A1/en
Priority to CA002472124A priority patent/CA2472124A1/fr
Priority to EP02805808A priority patent/EP1458415A2/fr
Publication of WO2003055528A2 publication Critical patent/WO2003055528A2/fr
Publication of WO2003055528A3 publication Critical patent/WO2003055528A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L’invention concerne des composés amphiphiles, à usage pharmaceutique ou cosmétique, constitués d’un complexe de paire d’ions entre un acyl aminoacide et une molécule biologiquement active. Lesdits composés formés permettent d’améliorer les propriétés des molécules pharmaceutiques ou cosmétiques en particulier des petites molécules organiques, des peptides et des protéines, des nucléotides ou des gènes.
PCT/FR2002/004561 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique WO2003055528A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/499,542 US20050069513A1 (en) 2001-12-27 2002-12-24 Amphiphilic compounds for pharmaceutical or cosmetic use
AU2002364684A AU2002364684A1 (en) 2001-12-27 2002-12-24 Amphiphilic compounds for pharmaceutical or cosmetic use
CA002472124A CA2472124A1 (fr) 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique
EP02805808A EP1458415A2 (fr) 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01/16936 2001-12-27
FR0116936A FR2834215B1 (fr) 2001-12-27 2001-12-27 Composes amphiphiles a usage pharmaceutique ou cosmetique

Publications (2)

Publication Number Publication Date
WO2003055528A2 WO2003055528A2 (fr) 2003-07-10
WO2003055528A3 true WO2003055528A3 (fr) 2004-02-26

Family

ID=8871028

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/004561 WO2003055528A2 (fr) 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique

Country Status (6)

Country Link
US (1) US20050069513A1 (fr)
EP (1) EP1458415A2 (fr)
AU (1) AU2002364684A1 (fr)
CA (1) CA2472124A1 (fr)
FR (1) FR2834215B1 (fr)
WO (1) WO2003055528A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2959936B1 (fr) * 2010-05-14 2012-08-03 Physica Pharma Composition nasales a visee systemique a base de cocoyl proline ou d 'au moins un de ses constituants
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
FR2971943B1 (fr) * 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques a action locale administrables par application cutanee

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
WO2001035998A1 (fr) * 1999-11-12 2001-05-25 Pharmaderm Laboratories, Ltd. Compositions pour administration transdermique et transmuqueuse d'agents therapeutiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US442090A (en) * 1890-12-02 Edwin t
DE2111361B2 (de) * 1971-03-10 1973-02-15 Verwendung von n-acylaminosaeuren, deren salzen und/oder estern als emulgatoren
FR2289179A1 (fr) * 1974-10-28 1976-05-28 Morelle Jean Sels metalliques de lipoaminoacides
US4837026A (en) * 1985-10-03 1989-06-06 Rajakhyaksha Vithal J Transdermal and systemic preparation and method
JP3202777B2 (ja) * 1992-01-24 2001-08-27 リンテック株式会社 経皮吸収促進剤及びテープ製剤
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
FR2828102B1 (fr) * 2001-03-28 2004-07-09 Ifc Sa Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
WO2001035998A1 (fr) * 1999-11-12 2001-05-25 Pharmaderm Laboratories, Ltd. Compositions pour administration transdermique et transmuqueuse d'agents therapeutiques

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GULATI MONICA ET AL: "Lipophilic drug derivatives in liposomes.", INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 165, no. 2, 14 May 1998 (1998-05-14), pages 129 - 168, XP002214801, ISSN: 0378-5173 *
NASH R A ET AL: "The possibility of lidocaine ion pair absorption through excised hairless mouse skin.", SKIN PHARMACOLOGY: THE OFFICIAL JOURNAL OF THE SKIN PHARMACOLOGY SOCIETY. SWITZERLAND 1992, vol. 5, no. 3, 1992, pages 160 - 170, XP002044700, ISSN: 1011-0283 *
TONDRE C ET AL: "Properties of the amphiphilic films in mixed cationic/anionic vesicles: a comprehensive view from a literature analysis.", ADVANCES IN COLLOID AND INTERFACE SCIENCE. NETHERLANDS 8 OCT 2001, vol. 93, no. 1-3, 8 October 2001 (2001-10-08), pages 115 - 134, XP002214799, ISSN: 0001-8686 *
VALENTA C ET AL: "The dermal delivery of lignocaine: Influence of ion pairing.", INTERNATIONAL JOURNAL OF PHARMACEUTICS (KIDLINGTON)., vol. 197, no. 1-2, 20 March 2000 (2000-03-20), pages 77 - 85, XP002214800, ISSN: 0378-5173 *
WOO G T ET AL: "EMULSIONS PREPARED BY INTERFACIAL ION PAIR FORMATIONS BETWEEN AMINO ACIDS AND FATTY ACIDS", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 76, no. 11, 1987, pages S306, XP002214798, ISSN: 0022-3549 *

Also Published As

Publication number Publication date
EP1458415A2 (fr) 2004-09-22
WO2003055528A2 (fr) 2003-07-10
CA2472124A1 (fr) 2003-07-10
US20050069513A1 (en) 2005-03-31
AU2002364684A1 (en) 2003-07-15
FR2834215B1 (fr) 2004-07-16
FR2834215A1 (fr) 2003-07-04

Similar Documents

Publication Publication Date Title
WO2005003296A3 (fr) Proteines hybrides d'albumine
WO2007073489A3 (fr) Molécules pour administration de gènes et thérapie génique et méthodes d'utilisation de celles-ci
WO2002014485A3 (fr) Nouveau gene kallikreine
WO2003030821A3 (fr) Proteines de fusion d'albumine
WO2005051902A8 (fr) Canal proteique mscl modifie
WO2006122971A3 (fr) Traitement de maladies a l'aide d'un systeme d'expression regulee, ameliore
WO2003055528A3 (fr) Composes amphiphiles a usage pharmaceutique ou cosmetique
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1097993A3 (fr) Molécules ribozymiques chimériques fonctionelles capables de glisser
WO2003092736A3 (fr) Conjugues comportant des acides nucleiques peptidiques
AU2001288363A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002258630A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2002079384A9 (fr) Proteines transporteurs humaines isolees, molecules d'acides nucleiques codant ces proteines transporteurs humaines et utilisations correspondantes
AU2002229060A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2004206257A8 (en) Human SAA3 nucleic acid molecule, protein, and methods of use for same
AU2002303137A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2001081413A3 (fr) Proteines de transport humaines isolees, molecules d'acides nucleiques codant pour les proteines de transport humaines et utilisations associees
AU2001253804A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
EP1385991A4 (fr) Proteines enzymatiques humaines isolees, molecules d'acide nucleique codant lesdites proteines et utilisations associees
WO2003040357A3 (fr) Genes codant des proteines phosphoenolpyruvate-sucre phototransferase
WO2002018554A3 (fr) Proteines humaines isolees de metabolisation de medicaments, molecules d'acides nucleiques et utilisations associees
AU2001292769A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
AU2002245128A1 (en) Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
AU2002234023A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2002311750A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002805808

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2472124

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2002805808

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10499542

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP